Report of Foreign Issuer (6-k)
November 07 2017 - 4:17PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
W
ashington,
D.C.
20549
FORM
6-K
Report
of Foreign Private Issuer
Pursuant
to Rule 13a-16 or 15d-16
of the
Securities Exchange Act of 1934
For
the month of November 2017
Commission
File Number: 001-37643
KITOV
PHARMACEUTICALS HOLDINGS LTD.
(Translation
of registrant’s name into English)
One
Azrieli Center, Round Tower,
132 Menachem Begin Road,
Tel Aviv 6701101, Israel
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form
20-F ☒ Form 40-F ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____
Kitov
Pharmaceuticals Holdings Ltd. (the “Company” or the “Registrant”) is announcing that the Tel Aviv
Stock Exchange has updated the Registry of Securities of the Company on its public website (
www.tase.co.il
) as of November
6, 2017.
Below
is a summary of the updated Registry of Securities of the Company as of November 6, 2017:
Security
Name
|
|
|
ISIN
(Security Number)
|
|
|
|
Issued
and Outstanding
|
|
Ordinary Shares
|
|
|
IL0007650166
|
|
|
|
224,192,013
|
(1)
|
K
itov
N
asdaq
L
isted “
S
eries
A
”
W
arrants
|
|
|
IL0076501530
|
|
|
|
6,835,669
|
(2)
|
Series 7/14 options
*
|
|
|
IL0076500961
|
|
|
|
600,000
|
(3)
|
Kitov Underwriter Warrants
(11/2015)
*
|
|
|
IL0076501613
|
|
|
|
157,945
|
(4)
|
2016 Equity-Based Incentive
Plan – Options and RSUs
*
|
|
|
IL0076501795
|
|
|
|
23,685,215
|
(5)
|
Kitov Placement Agent
Warrants (7/2016)
*
|
|
|
IL0076501951
|
|
|
|
141,176
|
(6)
|
Kitov Investor Warrants
(7/2017)
*
|
|
|
IL0076502033
|
|
|
|
1,215,873
|
(7)
|
Kitov Placement Agent
Warrants (7/2017)
*
|
|
|
IL0076502116
|
|
|
|
170,222
|
(8)
|
*
Non-listed security
(1)
|
21
of such Ordinary Shares are dormant shares held in treasury. The 224,192,013 issued and
outstanding Ordinary Shares would be represented by 11,209,600.60 of our American Depositary
Shares (ADSs), as each of our ADSs represents 20 of our Ordinary Shares.
|
(2)
|
Each
Nasdaq
Listed “Series A” Warrant
is exercisable into one ADS of the Company. The aggregate number of ADSs into which the
issued and outstanding Kitov
Nasdaq
Listed
“Series A” Warrants could be exercised is 6,835,669, which would represent 136,713,380 of our Ordinary
Shares.
|
(3)
|
Each
Series 7/14 option is exercisable into 0.07692 Ordinary Shares of the Company. The aggregate
number of Ordinary Shares into which the issued and outstanding Series 7/14 options could
be exercised is 46,152. Such number of Ordinary Shares would be represented by 2,307.6
of our ADSs.
|
(4)
|
Each
Kitov Underwriter Warrant (11/2015) is exercisable into one ADS of the Company. The aggregate
number of ADSs into which the issued and outstanding Kitov Underwriter Warrants (11/2015)
could be exercised is 157,945, which would represent 3,158,900 of our Ordinary Shares.
|
(5)
|
Each of the outstanding Options or Restricted Share Units (“RSU”) which were issued by us pursuant
to our 2016 Equity-Based Incentive Plan is exercisable into one Ordinary Share of the Company. The 23,685,215 Ordinary Shares into
which the issued and outstanding Options and RSUs could be exercised would be represented by 1,184,260.75 of our ADSs.
|
(6)
|
Each
Kitov Placement Agent Warrant (7/2016) is exercisable into one ADS of the Company. The
aggregate number of ADSs into which the issued and outstanding Kitov Placement Agent
Warrants (7/2016) could be exercised is 141,176, which would represent 2,823,520 of our
Ordinary Shares.
|
(7)
|
Each
Kitov Investor Warrant (7/2017) is exercisable into one ADS of the Company. The aggregate
number of ADSs into which the issued and outstanding Kitov Investor Warrants (7/2017)
could be exercised is 1,215,873, which would represent 24,317,460 of our Ordinary Shares.
|
(8)
|
Each
Kitov Placement Agent Warrant (7/2017) is exercisable into one ADS of the Company. The
aggregate number of ADSs into which the issued and outstanding Kitov Placement Agent
Warrants (7/2017) could be exercised is 170,222, which would represent 3,404,440 of our
Ordinary Shares.
|
This
Form 6-K is incorporated by reference into each of the Registrant’s Registration Statements on Form F-3 filed with the Securities
and Exchange Commission on December 12, 2016 (Registration file numbers 333-207117, 333-211477 and 333-215037) and the
Registrant’s Registration Statement on Form S-8 filed with the Securities and Exchange Commission on May 20, 2016 (Registration
file number 333-211478), and the Registrant’s Registration Statement on Form S-8 filed with the Securities and Exchange
Commission on June 6, 2017 (Registration file number 333-218538).
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
KITOV
PHARMACEUTICALS HOLDINGS LTD.
|
|
|
November
7, 2017
|
By:
|
/s/
Simcha Rock
|
|
|
Simcha
Rock
|
|
|
Chief
Financial Officer
|
3
Kitov Pharma (NASDAQ:KTOV)
Historical Stock Chart
From Aug 2024 to Sep 2024
Kitov Pharma (NASDAQ:KTOV)
Historical Stock Chart
From Sep 2023 to Sep 2024